home / stock / otlc / otlc news

OTLC News and Press, Oncotelic Therapeutics Inc From 04/04/22

Stock Information
Company Name: Oncotelic Therapeutics Inc
Stock Symbol: OTLC
Market: OTC
Website: oncotelic.com
Menu
OTLC OTLC Quote OTLC Short OTLC News OTLC Articles OTLC Message Board
Get OTLC Alerts

News, Short Squeeze, Breakout and More Instantly...
OTLC - Oncotelic and Dragon Overseas Capital Limited Completed Joint Venture Transaction

AGOURA HILLS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) ( OTCQB:OTLC ), today announced the formation of a Joint Venture (“JV”) with Dragon Overseas Capital Limited (ȁ...
OTLC - Oncotelic to Present New Studies on its TGF-? Program at the American Association for Cancer Research (AACR) Annual Meeting 2022

AGOURA HILLS, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” or the “Company”) ( OTCQB:OTLC ), a leading developer of TGF-β therapeutics for oncology and virology, today announced that it will...

OTLC - Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit

AGOURA HILLS, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“ Oncotelic ” or the “Company”) ( OTCQB:OTLC ), and Marcus Evans are proud to announce Dr Anthony E. Maida, Chief Clinical Officer – Translationa...

OTLC - Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference

OT-101 is Oncotelic’s RNA Therapeutic Against TGF-β OT-101 has completed over six clinical trials against solid tumors with good efficacy OT-101 is currently undergoing a phase 1b trial in combination with IL-2 Multiple trials combining OT-101 with pembrolizumab ...
OTLC - Covid Stocks Could Represent Huge Value on Sale (NVAX, OTLC, PFE, AZN, MRNA, MRK, JNJ, BNTX)

Just when we started to think it was over, Omicron popped up and reminded us that this thing is a whole lot more complex than just a simple bug. The pandemic has been with us for two years now, and it looks more and more like it will be with us for a whole lot […] For further details...

OTLC - Oncotelic Presenting at BiotechGate Digital Partnering

OT-101 is Oncotelic’s RNA Therapeutic Against TGF-β OT-101 has completed over six clinical trials against solid tumors with good efficacy OT-101 is currently undergoing a phase 1b trial in combination with IL-2 Multiple trials combining OT-101 with pembrolizumab ...

OTLC - Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma

AGOURA HILLS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (" Oncotelic " or the "Company") ( OTCQB:OTLC ) , a leading developer of TGF-β therapeutics for oncology and virology, today announced that it has submitted a clinical stu...
OTLC - ONCOTELIC ANNOUNCES THAT ORF8 MUTATIONS ARE DRIVING THE EVOLUTION OF THE DELTA AND THE OMICRON VARIANTS.

AGOURA HILLS, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") ( OTCQB:OTLC ) , a leading developer of TGF-β therapeutics for oncology and virology, today announced that it has performed mutational analysis of S...

OTLC - Covid Stocks Set for Continued Interest on Global Omicron Surge (NVAX, OTLC, PFE, AZN, MRNA, MRK, JNJ, BNTX)

We are finally starting to get hard data on the Omicron variant of Covid-19 from its epicenter in Gauteng, South Africa. And that data, along with data on the variant from the UK, paint a picture of a flash fire spreading at unimaginable speed through populations likely already around the wor...

OTLC - Oncotelic's Dr. Anthony Maida to Present at 2nd Annual TGF-? for Immuno-Oncology Drug Development Summit in January 2022

--News Direct-- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and virology, today announced that the Company’s Chief Clinical Officer and Board Director, Dr. Anthony Maida, will ...
Previous 10 Next 10